Spots Global Cancer Trial Database for external beam radiation therapy
Every month we try and update this database with for external beam radiation therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer | NCT01100489 | Ductal Breast C... Estrogen Recept... Estrogen Recept... HER2-negative B... HER2-positive B... Invasive Ductal... Invasive Lobula... Male Breast Can... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Progesterone Re... Progesterone Re... Stage I Breast ... Stage II Breast... Tubular Ductal ... | external beam r... questionnaire a... therapeutic con... | 18 Years - | Case Comprehensive Cancer Center | |
| Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer | NCT01266642 | Ductal Breast C... Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... | External Beam R... External Beam R... Hypofractionate... Laboratory Biom... Quality-of-Life... Questionnaire A... Whole Breast Ir... Whole Breast Ir... | 40 Years - | M.D. Anderson Cancer Center | |
| Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma | NCT03197506 | Glioblastoma Gliosarcoma Supratentorial ... | External Beam R... Laboratory Biom... Pembrolizumab Radiation Thera... Temozolomide Therapeutic Con... | 18 Years - | Mayo Clinic | |
| A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma | NCT04900792 | Glioblastoma Glioblastoma Mu... | Ferumoxytol inj... Pharmacological... External beam r... Temozolomide | 18 Years - | University of Iowa | |
| Modeling Clinical Failure in Prostate Cancer Patients Based on a Two-stage Statistical Model | NCT03979079 | Prostate Cancer | external beam r... | 18 Years - | Institut Bergonié | |
| Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer | NCT01507428 | Stage III Lung ... Stage IIIA Lung... Stage IIIB Lung... | 18F-Fluoromison... Carboplatin Computed Tomogr... Computed Tomogr... External Beam R... Fludeoxyglucose... Image-Guided Ad... Laboratory Biom... Paclitaxel Positron Emissi... Positron Emissi... | 18 Years - | National Cancer Institute (NCI) | |
| Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma | NCT00567567 | Localized Resec... Localized Unres... Recurrent Neuro... Regional Neurob... Stage 4 Neurobl... Stage 4S Neurob... | Autologous Hema... Carboplatin Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide External Beam R... Filgrastim Isotretinoin Laboratory Biom... Melphalan Peripheral Bloo... Pharmacological... Thiotepa Topotecan Hydro... Vincristine Sul... | - 30 Years | Children's Oncology Group | |
| Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer | NCT06129851 | Stage IIC Prost... Stage III Prost... Stage IV Prosta... | Biospecimen Col... Bone Scan Brachytherapy Computed Tomogr... Dual X-ray Abso... External Beam R... Magnetic Resona... PSMA PET Scan Questionnaire A... Relugolix | 18 Years - | University of Kansas Medical Center | |
| Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | NCT01560949 | Pancreatic Canc... | Oxaliplatin Irinotecan 5-FU Gemcitabine Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer | NCT02177838 | Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage IV Squamo... Stage IVA Squam... Stage IVA Squam... Stage IVA Verru... Stage IVB Squam... Stage IVB Squam... Stage IVB Verru... Tongue Cancer | cetuximab cisplatin external beam r... laboratory biom... | 18 Years - | Rutgers, The State University of New Jersey | |
| Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma | NCT03197506 | Glioblastoma Gliosarcoma Supratentorial ... | External Beam R... Laboratory Biom... Pembrolizumab Radiation Thera... Temozolomide Therapeutic Con... | 18 Years - | Mayo Clinic | |
| Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy | NCT02710253 | Hematopoietic a... Metastatic Mali... | External Beam R... Laboratory Biom... Stereotactic Bo... | 18 Years - | M.D. Anderson Cancer Center | |
| Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery | NCT04169763 | Stage II Vulvar... Stage III Vulva... Stage IIIA Vulv... Stage IIIB Vulv... Stage IIIC Vulv... Stage IVA Vulva... | Cisplatin External Beam R... Nelfinavir | 18 Years - | M.D. Anderson Cancer Center | |
| Prostate Margin Reduction to Reduce Acute Rectal Toxicity (PROTRACT) | NCT04004858 | Prostate Cancer | External beam r... | 18 Years - | Southlake Regional Health Centre | |
| Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer | NCT00012012 | Cervical Cancer Radiation Toxic... | Amifostine trih... Cisplatin Intracavitary b... External beam r... | 18 Years - | Radiation Therapy Oncology Group | |
| Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer | NCT04214067 | Endometrial End... Stage I Uterine... Stage II Uterin... | Biospecimen Col... Brachytherapy Computed Tomogr... External Beam R... Magnetic Resona... Pembrolizumab Quality-of-Life... Questionnaire A... X-Ray Imaging | 18 Years - | National Cancer Institute (NCI) | |
| A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer | NCT00352690 | Carcinoma, Non-... | Paclitaxel poli... Carboplatin External beam r... | 18 Years - | Washington University School of Medicine | |
| Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT02227901 | Adult Giant Cel... Adult Glioblast... Adult Gliosarco... | Tipifarnib External Beam R... Temozolomide Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Observation or Radical Treatment in Patients With Prostate Cancer | NCT00499174 | Prostate Cancer | conventional su... brachytherapy external beam r... Biopsies | 18 Years - | Canadian Cancer Trials Group | |
| Radiation Boost for Newly Diagnosed Glioblastoma Multiforme | NCT00376103 | Glioblastoma Mu... | temozolomide Brachytherapy External Beam R... | 18 Years - | Methodist Healthcare | |
| Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer | NCT01023061 | Adenocarcinoma ... Stage II Prosta... Stage III Prost... Stage IV Prosta... | abiraterone ace... prednisone leuprolide acet... laboratory biom... external beam r... goserelin aceta... | 18 Years - | University of Washington | |
| Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan. | NCT00590031 | Esophageal Carc... | Cisplatin Irinotecan External Beam R... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia | NCT00017004 | Anemia Cervical Adenoc... Cervical Adenos... Cervical Squamo... Drug Toxicity Radiation Toxic... Stage IIB Cervi... Stage III Cervi... Stage IVA Cervi... | External Beam R... Cisplatin Internal Radiat... Epoetin Alfa | - | GOG Foundation | |
| Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer | NCT00369122 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Stage IB Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... | Bevacizumab Cisplatin External Beam R... Internal Radiat... | - | National Cancer Institute (NCI) | |
| Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer | NCT01414608 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Stage IB Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage IIIB Cerv... Stage IVA Cervi... | Brachytherapy Carboplatin Cisplatin External Beam R... Paclitaxel Quality-of-Life... | 18 Years - | GOG Foundation | |
| Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma | NCT01013285 | Brain and Centr... | bevacizumab temozolomide external beam r... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer | NCT02830594 | Gastric Adenoca... Gastric Squamou... Gastroesophagea... Metastatic Mali... Stage IV Esopha... Stage IV Esopha... | External Beam R... Laboratory Biom... Pembrolizumab | 18 Years - | City of Hope Medical Center | |
| Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer | NCT01507428 | Stage III Lung ... Stage IIIA Lung... Stage IIIB Lung... | 18F-Fluoromison... Carboplatin Computed Tomogr... Computed Tomogr... External Beam R... Fludeoxyglucose... Image-Guided Ad... Laboratory Biom... Paclitaxel Positron Emissi... Positron Emissi... | 18 Years - | National Cancer Institute (NCI) | |
| Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | NCT03786783 | Ganglioneurobla... High Risk Neuro... | Autologous Hema... Carboplatin Cisplatin Cyclophosphamid... Dexrazoxane Dinutuximab Doxorubicin Etoposide External Beam R... Isotretinoin Melphalan Sargramostim Thiotepa Topotecan Vincristine | - 30 Years | National Cancer Institute (NCI) | |
| Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer | NCT01807065 | Adenocarcinoma ... Bone Metastases Hormone-resista... Recurrent Prost... Soft Tissue Met... Stage IV Prosta... | sipuleucel-T external beam r... laboratory biom... | 18 Years - | City of Hope Medical Center | |
| Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma | NCT01013285 | Brain and Centr... | bevacizumab temozolomide external beam r... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma | NCT03506139 | Glioblastoma Glioblastoma Mu... | External beam r... | 18 Years - | University of Iowa | |
| Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia | NCT00017004 | Anemia Cervical Adenoc... Cervical Adenos... Cervical Squamo... Drug Toxicity Radiation Toxic... Stage IIB Cervi... Stage III Cervi... Stage IVA Cervi... | External Beam R... Cisplatin Internal Radiat... Epoetin Alfa | - | GOG Foundation | |
| Radiation Boost for Newly Diagnosed Glioblastoma Multiforme | NCT00376103 | Glioblastoma Mu... | temozolomide Brachytherapy External Beam R... | 18 Years - | Methodist Healthcare | |
| Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM | NCT00548938 | Glioblastoma Mu... High-Grade Glio... | Gliadel wafer Temozolomide External Beam R... | 18 Years - 72 Years | Methodist Healthcare | |
| Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery | NCT01101451 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Stage I Cervica... Stage IA Cervic... Stage IB Cervic... Stage IIA Cervi... | Cisplatin External Beam R... Intensity-Modul... Laboratory Biom... Quality-of-Life... Questionnaire A... | 18 Years - | GOG Foundation | |
| Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer | NCT00307723 | Pancreatic Canc... Pancreatic Duct... | bevacizumab 5-Fluorouracil Oxaliplatin gemcitabine External Beam R... | 18 Years - | Massachusetts General Hospital | |
| Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer | NCT02177838 | Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage IV Squamo... Stage IVA Squam... Stage IVA Squam... Stage IVA Verru... Stage IVB Squam... Stage IVB Squam... Stage IVB Verru... Tongue Cancer | cetuximab cisplatin external beam r... laboratory biom... | 18 Years - | Rutgers, The State University of New Jersey | |
| Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer | NCT01590017 | Cervical Cancer Acquired Immuno... | cisplatin external beam r... | 18 Years - 120 Years | AIDS Malignancy Consortium | |
| Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer | NCT00052559 | Adenocarcinoma ... Stage II Rectal... Stage III Recta... | bevacizumab fluorouracil external beam r... therapeutic con... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Palliative Radiation Therapy in Reducing Pain in Patients With Bone Metastasis | NCT02699697 | Malignant Neopl... Metastatic Mali... Pain | External Beam R... Palliative Radi... Quality-of-Life... Questionnaire A... | - | Wake Forest University Health Sciences | |
| Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer | NCT06323460 | Clinical Stage ... Clinical Stage ... Oropharyngeal S... | Biospecimen Col... Carboplatin Cisplatin Computed Tomogr... External Beam R... Paclitaxel Positron Emissi... Questionnaire A... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies | NCT00335998 | Recurrent Cervi... Recurrent Ovari... Recurrent Vagin... Recurrent Vulva... Stage III Vagin... Stage IIIA Cerv... Stage IIIA Ovar... Stage IIIA Vulv... Stage IIIB Cerv... Stage IIIB Ovar... Stage IIIB Vulv... Stage IIIC Ovar... Stage IIIC Vulv... Stage IV Ovaria... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... | triapine laboratory biom... external beam r... brachytherapy cisplatin pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma | NCT03210662 | Primary Mediast... Recurrent Aggre... Recurrent Matur... Recurrent Non-H... Recurrent T-Cel... Recurrent Trans... Refractory Aggr... Refractory Non-... Refractory T-Ce... Refractory Tran... Transformed Mar... | External Beam R... Pembrolizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery | NCT04169763 | Stage II Vulvar... Stage III Vulva... Stage IIIA Vulv... Stage IIIB Vulv... Stage IIIC Vulv... Stage IVA Vulva... | Cisplatin External Beam R... Nelfinavir | 18 Years - | M.D. Anderson Cancer Center | |
| Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia | NCT00017004 | Anemia Cervical Adenoc... Cervical Adenos... Cervical Squamo... Drug Toxicity Radiation Toxic... Stage IIB Cervi... Stage III Cervi... Stage IVA Cervi... | External Beam R... Cisplatin Internal Radiat... Epoetin Alfa | - | GOG Foundation | |
| Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer | NCT00941070 | Recurrent Cervi... Recurrent Vagin... Stage IB Cervic... Stage II Vagina... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Vagin... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... Therapy-related... | triapine cisplatin external beam r... quality-of-life... questionnaire a... fludeoxyglucose... positron emissi... computed tomogr... | 18 Years - | National Cancer Institute (NCI) | |
| Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | NCT01798004 | Ganglioneurobla... Stage 1 Neurobl... Stage 2 Neurobl... Stage 2A Neurob... Stage 2B Neurob... Stage 3 Neurobl... Stage 4 Neurobl... Stage 4S Neurob... | Autologous Hema... Busulfan Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide External Beam R... Filgrastim Laboratory Biom... Melphalan Mesna Peripheral Bloo... Pharmacological... Topotecan Hydro... Vincristine Sul... | - 30 Years | Children's Oncology Group | |
| Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma | NCT01446809 | Stage IIA Adult... Stage III Adult... Stage IV Adult ... | Doxorubicin Hyd... External Beam R... Ifosfamide Laboratory Biom... Pazopanib Hydro... Pharmacological... Placebo Therapeutic Con... | 18 Years - | University of Washington | |
| PP-Gemcitabine & External Beam Radiation-Sarcomas | NCT02046304 | Sarcoma | Gemcitabine Radiation Thera... | - | M.D. Anderson Cancer Center | |
| Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy | NCT03543189 | Prostate Cancer Prostate Diseas... | Nivolumab Brachytherapy External Beam R... Androgen Depriv... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer | NCT00085631 | Cervical Cancer | cisplatin hyperthermia tr... brachytherapy external beam r... | 18 Years - | Duke University | |
| Post Market Clinical Follow-up Study Venezia | NCT03958357 | Cervical Cancer | Advanced Gyneco... | 18 Years - | Nucletron Operations BV | |
| Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer | NCT05946213 | Stage III Prost... Stage IVA Prost... | External Beam R... Stereotactic Bo... | 18 Years - | NRG Oncology | |
| Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCC | NCT04611165 | Advanced Hepato... | Nivolumab | 20 Years - | National Cancer Center, Korea | |
| Ketogenic Diet Phase 1 for Head & Neck Cancer | NCT01975766 | Head and Neck N... | Ketogenic diet External beam r... | 18 Years - | University of Iowa | |
| Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients | NCT00437372 | Cancer Head and Neck C... Pelvic Cancer Nervous System ... Thoracic Neopla... | Sunitinib External Beam R... | 18 Years - | Thomas Jefferson University | |
| Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer | NCT01711515 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Stage IB2 Cervi... Stage II Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage IIIB Cerv... Stage IVA Cervi... | Cisplatin External Beam R... Internal Radiat... Ipilimumab Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer | NCT01414608 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Stage IB Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage IIIB Cerv... Stage IVA Cervi... | Brachytherapy Carboplatin Cisplatin External Beam R... Paclitaxel Quality-of-Life... | 18 Years - | GOG Foundation | |
| Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | NCT00006094 | Adenocarcinoma ... Stage II Rectal... Stage III Recta... | oxaliplatin fluorouracil external beam r... | 18 Years - | National Cancer Institute (NCI) | |
| Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder | NCT02621151 | Muscle-invasive... | Pembrolizumab Transurethral R... Gemcitabine External Beam R... | 18 Years - | NYU Langone Health | |
| Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer | NCT03109873 | Larynx Lip Oral Cavity Pharynx | External Beam R... Metformin Hydro... Placebo | 18 Years - 90 Years | Thomas Jefferson University | |
| Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma | NCT02306161 | Metastatic Ewin... Metastatic Mali... Metastatic Mali... Metastatic Mali... Metastatic Peri... Peripheral Prim... | Cyclophosphamid... Doxorubicin Doxorubicin Hyd... Etoposide Etoposide Phosp... External Beam R... Ganitumab Ifosfamide Stereotactic Ra... Therapeutic Sur... Vincristine Vincristine Sul... | - 50 Years | National Cancer Institute (NCI) | |
| Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer | NCT00369122 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Stage IB Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... | Bevacizumab Cisplatin External Beam R... Internal Radiat... | - | National Cancer Institute (NCI) | |
| Prostate Margin Reduction to Reduce Acute Rectal Toxicity (PROTRACT) | NCT04004858 | Prostate Cancer | External beam r... | 18 Years - | Southlake Regional Health Centre | |
| Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer | NCT05946213 | Stage III Prost... Stage IVA Prost... | External Beam R... Stereotactic Bo... | 18 Years - | NRG Oncology | |
| Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer | NCT01367301 | Stage IA Uterin... Stage IB Uterin... Stage IC Uterin... Stage IIA Uteri... Stage IIB Uteri... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri... Uterine Carcino... | paclitaxel carboplatin external beam r... brachytherapy intensity-modul... laboratory biom... | 18 Years - | Albert Einstein College of Medicine | |
| Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer | NCT02705612 | Cervical Cancer | Cisplatin External Beam R... Internal Radiat... nimotuzumab | 18 Years - 70 Years | Air Force Military Medical University, China | |
| Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy | NCT03543189 | Prostate Cancer Prostate Diseas... | Nivolumab Brachytherapy External Beam R... Androgen Depriv... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Trastuzumab and External Beam Radiation Therapy in Treating Women With Stage III or Stage IV Breast Cancer | NCT00943410 | Breast Cancer | external beam r... Herceptin | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 | NCT05570422 | Cervical Cancer | KRC-01 External Beam R... cisplatin brachytherapy | 18 Years - | Kortuc, Inc. | |
| Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery | NCT04169763 | Stage II Vulvar... Stage III Vulva... Stage IIIA Vulv... Stage IIIB Vulv... Stage IIIC Vulv... Stage IVA Vulva... | Cisplatin External Beam R... Nelfinavir | 18 Years - | M.D. Anderson Cancer Center | |
| External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas | NCT01012609 | Brain Cancer | cetuximab in co... | 3 Years - 21 Years | Memorial Sloan Kettering Cancer Center | |
| Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | NCT01798004 | Ganglioneurobla... Stage 1 Neurobl... Stage 2 Neurobl... Stage 2A Neurob... Stage 2B Neurob... Stage 3 Neurobl... Stage 4 Neurobl... Stage 4S Neurob... | Autologous Hema... Busulfan Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide External Beam R... Filgrastim Laboratory Biom... Melphalan Mesna Peripheral Bloo... Pharmacological... Topotecan Hydro... Vincristine Sul... | - 30 Years | Children's Oncology Group | |
| A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma | NCT04900792 | Glioblastoma Glioblastoma Mu... | Ferumoxytol inj... Pharmacological... External beam r... Temozolomide | 18 Years - | University of Iowa | |
| Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy | NCT04920344 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Oropharyngeal H... | Transoral Surge... External Beam R... Cisplatin Incisional Tumo... Circulating tum... MD Anderson Dys... University of W... Euro-QOL 5 dime... Modified barium... | 18 Years - | Rutgers, The State University of New Jersey | |
| Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer | NCT01725165 | Recurrent Lung ... Stage IV Non-Sm... | Clinical Observ... External Beam R... Laboratory Biom... Quality-of-Life... Standard Follow... Therapeutic Con... | 18 Years - | M.D. Anderson Cancer Center | |
| Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT02227901 | Adult Giant Cel... Adult Glioblast... Adult Gliosarco... | Tipifarnib External Beam R... Temozolomide Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma | NCT05800405 | Recurrent Diffu... Refractory Diff... | Biospecimen Col... Chimeric Antige... Computed Tomogr... External Beam R... Leukapheresis Magnetic Resona... Positron Emissi... | 18 Years - | City of Hope Medical Center | |
| Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary | NCT03396471 | Carcinoma, Unsp... | Pembrolizumab External Beam R... | 18 Years - | Hoosier Cancer Research Network |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
